Alexandria Real Estate Equities has had a difficult run over the past few years, yet current checks suggest the stock may now trade at a discount to its intrinsic value based on a Discounted Cash Flow (DCF) estimate and market multiples. The question for investors is whether that apparent discount adequately reflects the risks that have weighed on the share price.

• The share price has declined 68.4% over the past 5 years, which signals that expectations around the business and its cash flows have reset significantly.
• The recent delivery of a 427,000 rentable square feet research and development hub for Bristol Myers Squibb at Alexandria's San Diego megacampus can support long term cash flow visibility. However, any setbacks in leasing or tenant demand for life science space may limit how much value the market is willing to assign to those assets.
• The company screens as undervalued on both its Discounted Cash Flow (DCF) intrinsic value estimate and key market multiples. Yet a mixed value score that finds Alexandria Real Estate Equities attractively priced on 4 of 6 checks, as shown here, points to a more nuanced picture than a straightforward bargain.

The stock's next move may depend on whether that roughly 14.8% implied discount to intrinsic value offers enough compensation for the risks that produced such a steep multi year decline in Alexandria Real Estate Equities' share price.

Is Alexandria Real Estate Equities a Bargain on Cash Flow?

The Discounted Cash Flow (DCF) model here uses adjusted funds from operations to estimate what Alexandria Real Estate Equities might be worth based on its future cash generation to shareholders.

On this view, Alexandria Real Estate Equities is modeled on $1.53b of latest twelve month free cash flow and a broadly steady to modestly growing cash flow profile over time. That stream of cash flows leads to an intrinsic value estimate of about $60.34 per share, which sits roughly 14.8% above the current share price and suggests the stock is trading below the modelled cash flow value. The recent delivery of the 427,000 square foot Bristol Myers Squibb hub helps explain why the market is still prepared to pay for long term cash flow, even if it is not fully aligning with the DCF estimate today.

On this DCF view, Alexandria Real Estate Equities currently appears undervalued relative to its modelled intrinsic value.

Our Discounted Cash Flow (DCF) analysis suggests Alexandria Real Estate Equities is undervalued by 14.8%. Track this in your watchlist or portfolio, or discover 51 more high quality undervalued stocks.

Is Alexandria Real Estate Equities a Bargain on Sales?

P/S is a useful lens for Alexandria Real Estate Equities because investors often look at revenue-based multiples to compare real estate investment trusts that can have volatile earnings or large non cash charges.

Alexandria Real Estate Equities currently trades on a P/S ratio of about 3.1x, which sits well below the Health Care REITs industry average of roughly 7.0x and a peer average near 7.1x. The stock also screens below an internal fair P/S estimate of about 4.5x, which is the level suggested once its size, margins and risk profile are taken into account.

On this basis, the market price implies a discount to both broad sector benchmarks and the more tailored fair multiple for Alexandria Real Estate Equities, even after factoring in the concerns that have weighed on the shares.

Overall, Alexandria Real Estate Equities appears undervalued on its current P/S multiple compared with both peers and a reasonable fair value range.

The Alexandria Real Estate Equities Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where Alexandria Real Estate Equities' valuation puzzle leaves off. They spell out which assumptions on growth, margins and earnings would need to hold for the stock to be worth meaningfully more or less than today's price, and each one sets out fair value as a thesis about the business that you can revisit over time. You can find these Narratives on Simply Wall St's Community page.

Community views on Alexandria Real Estate Equities sit far apart, with some investors focused on asset value support while others worry about structural headwinds.

Bull case: 42% undervalued

"After adjustments (e.g., a 10% reduction in NAV), intrinsic value remains well above the current share price…"

Bear case: 22% overvalued

"Rising costs, regulatory pressures, and shifts in workplace demand are squeezing margins and threatening predictability of earnings and occupancy rates…"

Do you think there's more to the story for Alexandria Real Estate Equities? Head over to our Community to see what others are saying!

The Bottom Line

For Alexandria Real Estate Equities, both the Discounted Cash Flow (DCF) intrinsic value estimate and the current P/S multiple point to an undervalued stock, although the broader set of checks is only mixed rather than unanimously strong. The key question is whether the implied 14.8% discount to intrinsic value is compensation for genuine long term risk around leasing, tenant demand and occupancy, or whether it reflects investor caution that may eventually ease. What matters most from here is how reliably Alexandria Real Estate Equities can keep research and development space leased on attractive terms. That will decide whether the current discount proves to be opportunity or a value trap.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.